What is cancer?
Cancer risk factors
Cancer symptoms
Stages of cancer
General cancer information
Acute leukaemia
Anal cancer
Bile duct cancer
Bladder cancer
View all cancer types >
Cancer Statistics NSW
NSW Cancer Plan
Document library
T.I.P.S. to improve your cancer care
Reduce your cancer risk
Preventing skin cancer
Quit smoking
Damaging effects of vaping
Campaigns
Bowel cancer screening
Breast cancer screening
Cervical screening
Smoking Cessation Framework
NSW Skin Cancer Prevention Strategy
Helping Mob Live Healthy and Prevent Cancer Toolkit
Cancer screening toolkit
Noticing symptoms
Seeing a GP
Having tests
Seeing specialists
Understanding your diagnosis
Getting a second opinion
Navigating the health system
Planning treatment
Types of treatment
Clinical trials
Side effects
Changes to treatment
Finishing treatment
Find a specialist or cancer service
Learn about cancer specialist centres
Cancer treatment protocols
Treatment information resources
Telling other people
Physical wellbeing
Emotional wellbeing
Survivorship
Having advanced cancer
End of life concerns
Cancer costs
Transport and accommodation
Money, legal and work issues
Help at home
Travel and holidays
People with cancer
Carers
Young People
Aboriginal people
Multicultural communities
People in rural and remote areas
Translational cancer research
Research Career Support
Cancer researchers in NSW
CanDLe Program
Request or submit data
Publications using our data
How do clinical trials progress?
Find a cancer clinical trial in NSW
Grant opportunities
Research Grants
Grants we've funded
How to apply
Reporting requirements
Resources and publications
Events
Overriding principles
Priority areas
System enablers
Working together
Performance index
Patient-reported measures (PRMs)
Reporting for Better Cancer Outcomes (RBCO)
Leading Better Value Care
Primary Care Cancer Control Quality Improvement Toolkit
Find out more about the recipient of the 2019 Translational Program Grant and their research project.
The University of Sydney
Professor Paul Keall
Cancer imaging and targeted radiation therapy: Innovation, discovery and translation
$3,750,000